What is Thalidomide being used for today?
Since July 16, 1998, thalidomide is licensed for use in the United States in treating complications related to leprosy. Since October 26, 2006, it is also authorized in cases of Multiples Myeloma; its distribution being exclusively controlled by the S.T.E.P.S. Program. To learn more about the S.T.E.P.S. Program, please visit http://www.thalomid.com/steps_program.aspx In Canada, thalidomide is not marketed; however, it is available through Health Canada’ Special Access Program (http://www.hc-sc.gc.ca/dhp-mps/acces/drugs-drogues/sapfs_pasfd_2002-eng.php) Although licensed for use in leprosy on July 16, 1998 and for use in Multiple Myeloma since October 26, 2006 in the United States, thalidomide has been and is being used for a wide range of conditions and diseases throughout North America.